Central nervous system uptake of intranasal glutathione in Parkinson's disease npj Parkinson's Disease Glutathione IV Therapy The Parkinson's Plan Targeting ferroptosis with the lipoxygenase inhibitor PTC 041 as a therapeutic strategy for the treatment of Parkinson's disease PLOS One Transient glutathione depletion in the substantia nigra compacta is associated with neuroinflammation in rats ScienceDirect I would like to know if there is any work on the use of Glutathione. I found an in vitro publication that Glutathione could be a protective factor and catecholamines like dopamine Dr. Joseph C. Maroon is a neurosurgeon and a professor at the University of Pittsburgh Medical Center. His research on Alzheimers and Parkinsons disease focuses on the role of oxidative stress and